May 16, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me PYC Therapeutics, an Australia-based developer of RNA therapies, reported initial results from its Phase 1 PLATYPUS clinical trial in the US for an RNA therapy known as VP-001...
May 14, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me A team of genetic researchers from the UK, US, and Switzerland has identified a mutation in the gene TMEM216 as a common cause of retinitis pigmentosa (RP) in people with African...
May 10, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me EyeDNA Therapeutics, a subsidiary of Paris-based Coave Therapeutics, reported encouraging 24-month results for 17 adult patients in its Phase ½ PDE6B gene therapy clinical trial...
May 8, 2024 | Media, News, Science, YouTube
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me The Philly Phorum on May 6, 2024, provided a platform for professionals serving the blind and low vision community in Philadelphia and surrounding areas to showcase services and...
May 8, 2024 | Alabama, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Retinal Physician recently interviewed several co-founders of the Young Uveitis Specialists (YUS) to discuss the objectives of this recently established subgroup within AUS ,...
May 2, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Atsena Therapeutics, a company developing innovative gene therapies for inherited retinal diseases, has reported both structural and functional vision improvements for patients...
